Español
Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Recombinant Human Papillomavirus (HPV) Bivalent Vaccine

listen  (ree-KOM-bih-nunt HYOO-mun PA-pih-LOH-muh-VY-rus by-VAY-lent vak-SEEN)

This page contains brief information about recombinant human papillomavirus (HPV) bivalent vaccine and a collection of links to more information about the use of this vaccine, research results, and ongoing clinical trials.

US Brand Name(s): Cervarix
FDA Approved: Yes

FDA Approval for a Recombinant Human Papillomavirus (HPV) Bivalent Vaccine

Use in Cancer

Recombinant human papillomavirus (HPV) bivalent vaccine is approved to prevent some conditions caused by certain types of HPV. It is used in females aged 9 to 25 years to prevent the following:

More About Recombinant Human Papillomavirus (HPV) Bivalent Vaccine

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Human Papillomavirus (HPV) Vaccine - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Human Papillomavirus (HPV) and Cancer - Information about the use of this drug to prevent cancer.

Human Papillomavirus (HPV) Vaccines - Information about the use of this drug to prevent cancer.

Cancer Vaccines - Information about the use of this drug to prevent cancer.

Clinical Trials Accepting Patients

Find Clinical Trials for Human Papillomavirus 16/18 L1 Virus-like Particle/as04 Vaccine - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to TopBack to Top

  • Posted: May 7, 2010
  • Updated: July 31, 2014